Physician profile
Christopher Price
NPI 1205887510
$2,637.58
in general payments reported to CMS, 2019-2025
25 companies · $475 in 2025
The $475 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $212 · 2021: $376 · 2022: $432 · 2023: $369 · 2024: $543 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $774.05 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $446.20 | 2019-2025 | Intracept, General - Pain Management, General - Therapies |
| Abbvie INC. | $265.10 | 2021-2025 | |
| Si-Bone, INC. | $196.04 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $167.94 | 2022 | |
| Saluda Medical Americas, INC. | $101.42 | 2024-2025 | Evoke |
| Forte Bio-Pharma LLC | $85.14 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Nevro Corp. | $61.35 | 2019-2022 | |
| Grt US Holding, INC. | $60.42 | 2021-2022 | |
| Daiichi Sankyo INC. | $57.68 | 2019 | |
| Mml US, INC. | $51.11 | 2023-2025 | Reactiv8 |
| Globus Medical, INC. | $48.02 | 2025 | Senza |
| Pfizer INC. | $40.57 | 2020-2023 | |
| Biodelivery Sciences International, INC. | $38.11 | 2019-2021 | |
| Allergan, INC. | $31.80 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $29.80 | 2021 | |
| Scilex Pharmaceuticals INC. | $29.60 | 2023-2024 | Ztlido |
| Lilly USA, LLC | $25.69 | 2022 | |
| Collegium Pharmaceutical, INC. | $25.06 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $23.01 | 2024 | Horizant |
| Medtronic, INC. | $22.60 | 2024 | Synchromedii |
| Covidien LP | $18.23 | 2020 | |
| Conetic Solutions, INC. | $14.12 | 2024 | |
| Medtronic USA, INC. | $12.87 | 2019 | |
| Assertio Therapeutics, INC. | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.